Stephen J. Mattingly

The role of fluoroquinolones in the promotion of alginate synthesis and antibiotic resistance in Pseudomonas aeruginosa

Abstract. Treatment of nonmucoid Pseudomonas aeruginosa with gyrase inhibitors such as ciprofloxacin, norfloxacin, and ofloxacin, which target the A subunit of topoisomerase II, resulted in 100% conversion to the mucoid phenotype. However, antibiotics that partially inhibited growth and macromolecular synthesis (DNA, RNA, protein, or peptidoglycan) of nonmucoid isolates in a gluconate-limited chemostat culture system did not promote conversion to mucoid subpopulations. An increase in resistance was observed in populations that expressed the mucoid phenotype. Both mucoid conversion and antibiotic resistance were completely reversible when ciprofloxacin pressure was withdrawn, but only partially reversible by the removal of norfloxacin and ofloxacin. Thus, these experiments indicate that in the presence of some fluoroquinolones, a conditional response resulting in mucoid conversion and antibiotic resistance may occur.

Identification of the High-Virulence Clone of Group B Streptococci in Mexican Isolates by Growth Characteristics at 40°C

Abstract. Group B streptococci (GBS) colonizing the vagina and rectum of pregnant women cause invasive disease of the offspring in a small number of cases. The immune status of the host and differences in virulence among strains appear to be the main determinants for neonatal infection. A high-virulence clone (HVC) was proposed to cause much of the morbidity and mortality when a collection of GBS isolates was examined by multilocus enzyme electrophoresis. HVC isolates could be further distinguished by their inability to grow at 40°C. This characteristic was used in the present study to examine a collection of 57 GBS isolates from Mexico City for the HVC. Three serotype III invasive strains were classified in the HVC. The other eleven invasive strains and all carrier isolates had growth curves unaffected at 40°C. These results demonstrate the presence of the HVC in Mexico. Such a low prevalence could explain in part the low rate of GBS invasive neonatal disease in Mexico.

Lack of virulence of bovine type IIIStreptococcus agalactiae strains for mice correlates with reduced in vitro production of extracellular type-specific antigen

Six strains of type IIIStreptococcus agalactiae isolated from milk samples from cases of bovine mastitis were examined for in vitro production of three potential extracellular virulence factors: neuraminidase, protease, and extracellular type-specific antigen. Virulence in mice, expressed as LD50 values, was examined for these six strains to determine if a relationship existed between the in vitro production of any of the three extracellular products and mouse lethality. Only in vitro production of extracellular type-specific antigen showed a correlation with virulence of these organisms in the mouse model. All six bovine strains were relatively avirulent in the mouse while producing reduced levels in vitro of extracellular typespecific antigen as compared to nine human isolates. The bovineS. agalactiae strains were an average of 538-fold less virulent for the mouse than were the high type-specific antigen producers isolated from human sources.

Covalent linkage of the type- and group-specific antigens to the peptide moiety of the peptidoglycan of serotype III group BStreptococcus

The attachment sites for the two major cell wall polysaccharides, the type-and group-specific antigens of a serotype III group B streptococcus (GBS) were investigated with [14C]lysine to label the peptide portion of the peptidoglycan and [3H]acetate to label both polysaccharide antigens as well as the glycan backbone of the peptidoglycan. Mutanolysin-treated cell walls were subjected to trypsin digestion, followed by exhaustive beta-elimination with 6N ammonium hydroxide at 37°C. The resulting products were purified by column chromatography prior to chemical, immunological, and high-voltage electrophoresis analyses. Data from these studies indicated that both cell wall polymers are covalently attached to the peptidoglycan via the peptide unit. Additionally, during synthesis and assembly both antigens attached only to nascent peptidoglycan.

Effect of Antibiotics on Protease Production by a Viridans Streptococcus

A viridans streptococcus (Streptococcus MG intermedius 974) isolated from a confirmed case of subacute bacterial endocarditis was studied for the production of extracellular proteases during exponential growth and after penicillin (0.10 μg/ml) and/or streptomycin (20 μg/ml) treatment. Exponentially growing cultures produced a variety of extracellular proteases, as determined by the elution profiles of active proteins from Sephadex G-100 and Sepharose 4B columns. Examination of supernatant fluids from cultures of S. MG intermedius treated with penicillin or streptomycin for 12 h indicated a reduction of at least 50% in the number of different proteolytic species produced. However, some of the proteases produced by the cultures during penicillin or streptomycin treatment had significantly higher specific activities when compared with proteases produced by exponentially growing cells. The combination of penicillin and streptomycin further reduced both the number and the specific activities of the extracellular proteases on a cell dry weight basis.

Temperature sensitivity of fructose-1,6-biphosphate aldolase accounts for the inability of the high-virulence clone ofStreptococcus agalactiae to grow at 40°C

A high-virulence clone of serotype IIIStreptoccus agalactiae causing invasive neonatal disease has recently been identified by multilocus enzyme electrophoresis and can be further distinguished by its inability to grow at 40°C in a chemically defined medium. The basis for the unusual growth inhibition at 40°C was examined in the present study and shown to be owing to a temperature-sensitive fructose-1,6-bisphosphate aldolase (fba). Crude enzyme preparations (75% saturated ammonium sulfate precipitates) of fba obtained from a high-virulence clone demonstrated a 75% reduction in aldolase activity when preincubated at 40°C for 30 min compared with 37°C. In contrast, fba from a serotype III isolate obtained from an asymptomatically colonized infant demonstrated <10% decrease in activity at 40°C. Comparison of another enzyme, lactate dehydrogenase (ldh), from both organisms indicated no loss in activity at 40°C compared with 37°C. Glyceraldehyde-3-phosphate, one of the end-products of fba activity, relieved growth inhibition at 40°C.

Identification of the High-Virulence Clone of Group B Streptococci by Using a Probe Containing a Putative Aldolase Gene

A high-virulence clone (HVC) was proposed as causing much of the morbidity and mortality when a collection of group B Streptococcus (GBS) isolates was examined by multi-locus enzyme electrophoresis. HVC isolates could be further distinguished by their inability to grow at 40°C, and a temperature-sensitive aldolase was identified as responsible for this characteristic. In the present study, the HVC was sought in a collection of 57 GBS isolates by hybridization with a probe containing a putative aldolase gene on genomic DNA restriction enzyme digests. Isolates were initially classified as HVC or non-HVC by their inability to grow at 40°C. Three serotype III invasive isolates had the HVC control restriction/hybridization pattern. They were also unable to grow at 40°C. The remaining 11 invasive and all carrier isolates showed a pattern identical to that of the non-HVC control. These results provide additional support for the existence of a highly virulent clonal group among serotype III isolates and suggest that hybridization with a probe containing the aldolase gene on DNA restriction enzyme digests can be an alternative method for identifying highly virulent isolates.